ストックスクリーナーアプリを入手
0.2601
1.80%
0.0046
前日終値:
$0.2555
開ける：
$0.2536
24時間の取引高:
122.34K
Relative Volume:
0.39
時価総額：
$9.00M
収益：
$7.11M
当期純損益:
$-41.28M
株価収益率:
-0.1885
EPS:
-1.38
ネットキャッシュフロー:
$-26.84M
1週間 パフォーマンス:
+12.31%
1か月 パフォーマンス:
-29.30%
6か月 パフォーマンス:
-72.25%
1年 パフォーマンス:
-75.23%
1日の値動き範囲:
$0.25
$0.2718
1週間の範囲:
$0.23
$0.335
52週間の値動き範囲:
$0.2275
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
名前
Co Diagnostics Inc
セクター
電話
(801) 278-9769
住所
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
CODX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.267 | 8.39M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
133.16 | 231.29B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.68 | 157.07B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
378.38 | 146.67B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.03 | 104.07B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.70 | 44.71B | 5.54B | 4.18B | 623.10M | 7.00 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-08-12 | ダウングレード | Sidoti | Buy → Neutral |
| 2021-12-29 | 開始されました | Sidoti | Buy |
| 2021-03-29 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-05-20 | アップグレード | Maxim Group | Hold → Buy |
| 2020-05-18 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-03 | ダウングレード | Maxim Group | Buy → Hold |
すべてを表示
Co Diagnostics Inc (CODX) 最新ニュース
Co-Diagnostics Holds Annual Shareholders Meeting - TipRanks
Co-Diagnostics stock hits 52-week low at $0.27 amid market challenges - Investing.com Australia
HC Wainwright Predicts Co-Diagnostics Q1 Earnings - Defense World
Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright - Defense World
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference | CODX Stock News - GuruFocus
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference - The Manila Times
Co-Diagnostics, Inc. to Participate in D. Boral Capital Inaugural Global Conference on May 14, 2025 - Nasdaq
Co-Diagnostics Unveils Next-Gen PCR Testing Platform to Elite Institutional Investors - Stock Titan
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Co-Diagnostics Q1 2025 shows improved EPS and revenue decline - Investing.com Nigeria
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Stra - GuruFocus
Co-Diagnostics Q1 2025 Earnings Call Transcript - MarketBeat
Co-Diagnostics Inc (CODX) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid Revenue ... - Yahoo Finance
AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration - Business Wire
Co-Diagnostics Reports Q1 2025 Financial Results - TipRanks
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Inc Reports Q1 2025 Earnings: EPS Loss of $0.24 Beats Estimates, Revenue Falls Short at $0.1 Million - GuruFocus
Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results - The Manila Times
Examining the Future: Co-Diagnostics's Earnings Outlook - Nasdaq
Resmed acquires virtual diagnostics company VirtuOx - MassDevice
Co-Diagnostics (NASDAQ:CODX) Stock Rating Upgraded by D Boral Capital - Defense World
D. Boral Capital Initiates Coverage of Co-Diagnostics (LSE:0A50) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Relea - GuruFocus
Co-Diagnostics, Inc. Announces First Quarter 2025 Earnings Release Date and Webcast - GlobeNewswire
Co-Diagnostics Q1 2025 Earnings Coming May 8: Key Executive Team to Present Latest Financial Performance - Stock Titan
Stock Market Recap: Co-Diagnostics Inc (CODX) Concludes at 0.32, a -18.26 Surge/Decline - DWinneX
Co-Diagnostics (NASDAQ:CODX) Now Covered by Analysts at D. Boral Capital - Defense World
Co-Diagnostics expands sales agreement, adds Clear Street as agent By Investing.com - Investing.com Canada
Co-Diagnostics expands sales agreement, adds Clear Street as agent - Investing.com Australia
This Kohl's Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Benzinga
D. Boral Capital Initiates Coverage of Co-Diagnostics (CODX) with Buy Recommendation - Nasdaq
Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C. - Seeking Alpha
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results - Seeking Alpha
Co-Diagnostics Inc (NASDAQ: CODX): Is This The Time To Buy? - Marketing Sentinel
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges - Investing.com Canada
Co-Diagnostics stock hits 52-week low at $0.28 amid market challenges By Investing.com - Investing.com South Africa
Many med-tech company supply chains protected from tariffs - BioWorld MedTech
All You Need to Know About CoDiagnostics (CODX) Rating Upgrade to Buy - Yahoo Finance
Co-Diagnostics targets 2025 clinical evaluations for TB and HPV tests in India and South Africa - MSN
Co-Diagnostics Earnings Call: Progress Amid Challenges - MSN
HC Wainwright Lowers Co-Diagnostics (NASDAQ:CODX) Price Target to $1.00 - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q4 Loss, Misses Revenue Estimates - MSN
Co-Diagnostics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2024 Earnings Call Transcript - Insider Monkey
Co Diagnostics Inc (CODX) 財務データ
収益
当期純利益
現金流量
EPS
0.61%
0.24%
大文字化:
|
ボリューム (24 時間):